Physician profile
James K Wu
NPI 1427009356
$24,446.39
in general payments reported to CMS, 2019-2025
16 companies · $4,641 in 2025
The $4,641 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,316 · 2020: $2,212 · 2021: $3,120 · 2022: $1,570 · 2023: $5,427 · 2024: $2,160 · 2025: $4,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,070 · Travel and Lodging: $4,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,069.57 |
| Travel and Lodging | $4,158.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $7,234.67 | 2019-2025 | Evoque, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $5,430.71 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Medtronic Vascular, INC. | $3,357.55 | 2019-2020 | |
| Abbott Laboratories | $3,124.35 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Navitor, Portico |
| Abiomed | $2,238.39 | 2019-2025 | Impella |
| Medtronic, INC. | $1,036.93 | 2021-2025 | Corevalve Evolut R, Valiant Captivia, Avalus |
| Zimmer Biomet Holdings, INC. | $391.82 | 2019-2021 | |
| Bolton Medical INC | $275.07 | 2023-2025 | Treo Abdominal Stent-Graft System |
| Boston Scientific Corporation | $267.31 | 2019-2020 | |
| Kerecis Limited | $253.43 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| W. L. Gore & Associates, INC. | $247.02 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Biomerieux INC | $217.12 | 2022 | |
| Baxter Healthcare | $203.72 | 2019-2021 | |
| Livanova USA, INC. | $123.45 | 2022 | |
| Chiesi USA, INC. | $44.85 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.